Phil L'Huillier, PhD

Phil L'Huillier, PhD

Phil L'Huillier, PhDManaging Director
๐Ÿ’ผ Partner at Coparion โ†’
About

CatalYm develops antibodies that will neutralize the tumor-produced immune suppressant GDF-15 to increase immune cell infiltration into the tumor microenvironment, which can also potentiate the activity of (approved) checkpoint-blockers in fighting the tumor.

Focus Areas

["mobility"]

Location

๐Ÿ“ Based in Berlin

Verified Contact & Outreach Agent

Direct Professional Email Pattern

[email protected] | [email protected]

AI Outreach Agent Pitch Writer

Compose an personalized, high-converting outreach message targeting their exact investment interest...

Unlock Direct Partner Outreach

View verified contact information and use our active Outreach Composer agent to draft custom intro pitches in seconds.

Connect via GRID to Outreach

100% free account ยท Get started in 1-click